Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: J Psychiatr Res. 2015 Mar 21;64:32–39. doi: 10.1016/j.jpsychires.2015.03.011

Table 2.

The Effect of Stimulant Medication Exposure on Peak SBP, Average SBP Rise, Peak Heart Rate, and VO2max during the Maximal Treadmill Exercise Test in the Propensity Score-Matched Cohort while Adjusting for the 18 Covariates in the Model


Peak SBP Log of Average SBP Rise
Variable Parameter
Estimate
LS Mean
Estimate
Standard
Error
95% CI p value Parameter
Estimate
LS Mean
Estimate
Standard
Error
95% CI p value

Stimulant Use −0.91 1.48 (−3.82 to 2.00) 0.54a −0.023 0.030 (−0.083 to 0.036) 0.44b
  Yes 179.7 3.56 (172.7 to 186.7) 1.48 0.073 (1.34 to 1.62)
  No 180.6 3.39 (174.0 to 187.3) 1.50 0.069 (1.37 to 1.64)

Peak Heart Rate VO2max (mL/kg/min)
Variable Parameter
Estimate
LS Mean
Estimate
Standard
Error
95% CI p value Parameter
Estimate
LS Mean
Estimate
Standard
Error
95% CI p value

Stimulant Use −4.24 0.86 (−5.93 to −2.55) <.0001c 0.65 0.37 (−0.084 to 1.39) 0.083d
  Yes 170.2 2.02 (166.2 to 174.2) 34.8 0.88 (33.1 to 36.5)
  No 174.4 1.92 (170.7 to 178.2) 34.2 0.84 (32.5 to 35.8)

a

FDR–adjusted p=0.54

b

FDR–adjusted p=0.54

c

FDR–adjusted p=0.0004

d

FDR–adjusted p=0.16